Skip to main content
Seth Cohen, MD, Otolaryngology (ENT), Raleigh, NC

Seth Morris Cohen MD MPH

Laryngology & Voice Disorders


Professor, Head and Neck Surgery & Communication Sciences, Duke University School of Medicine

Join to View Full Profile
  • 3480 Wake Forest RdSuite 404Raleigh, NC 27609

  • Phone+1 800-385-3646

Dr. Cohen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Laryngology, 2005 - 2006
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Otolaryngology - Head and Neck Surgery, 2001 - 2005
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterInternship, Otolaryngology - Head and Neck Surgery, 2000 - 2001
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 2000

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2006 - 2026
  • TN State Medical License
    TN State Medical License 2002 - 2007
  • Otolaryngology
    American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Safeguarding Humanism in Healthcare - No Space for Antisemitism in MedicineFebruary 2025
  • Lessons in Humanism - What Can We Learn From Israeli HealthcareOctober 2024

Grant Support

  • Inhibitors of Cu-only Superoxide Dismutases as Novel AntifungalsUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2025
  • Inhibitors of Cu-only Superoxide Dismutases as Novel AntifungalsUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2025
  • Inhibitors of Cu-only Superoxide Dismutases as Novel AntifungalsUNIVERSITY OF CALIFORNIA, SAN DIEGO2024–2025
  • Fragment-based Discovery of COMT Inhibitors as a Novel Pharmacotherapy for AlcoholismUNIVERSITY OF CALIFORNIA, SAN DIEGO2023–2025
  • Targeting Metal-Dependent Epigenetic Modulators via MetalloPROTACsUNIVERSITY OF CALIFORNIA, SAN DIEGO2023–2025
  • Targeting Metal-Dependent Epigenetic Modulators via MetalloPROTACsUNIVERSITY OF CALIFORNIA, SAN DIEGO2023–2025
  • Targeting Metal-Dependent Epigenetic Modulators via MetalloPROTACsUNIVERSITY OF CALIFORNIA, SAN DIEGO2023–2025
  • Metal-binding Isosteres for Influenza Endonuclease Inhibitors and BeyondUNIVERSITY OF CALIFORNIA, SAN DIEGO2020–2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: